Elanco officer granted shares; some withheld for tax

Elanco Animal Health officer Ellen de Brabander reported equity compensation activity in the company’s common stock.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Elanco Animal Health officer Ellen de Brabander reported equity compensation activity in the company’s common stock. On April 1, 2026, she received a grant of 40,985 shares, recorded at no purchase price. On the same date, 20,288 shares were disposed of at $23.12 per share to satisfy tax obligations, a tax-withholding transaction rather than an open-market sale. Following these entries, she directly holds 280,821 shares of Elanco common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider de Brabander Ellen

Role SEE REMARKS

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	40,985	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	20,288	$23.12	$469K

Holdings After Transaction: Common Stock — 280,821 shares (Direct)

Key Figures

Stock grant: 40,985 shares Tax-withholding shares: 20,288 shares Tax-withholding price: $23.12 per share +1 more

4 metrics

Stock grant 40,985 shares Common stock grant on April 1, 2026

Tax-withholding shares 20,288 shares Shares withheld for taxes at $23.12 per share

Tax-withholding price $23.12 per share Value used for 20,288-share tax disposition

Shares held after transactions 280,821 shares Direct Elanco common stock holdings after April 1, 2026

Key Terms

Grant, award, or other acquisition, tax-withholding disposition, Payment of exercise price or tax liability by delivering securities

3 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

tax-withholding disposition financial

"transaction_action: tax-withholding disposition"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Payment of exercise price or tax liability by delivering securities financial

"transaction_code_description: Payment of exercise price or tax liability by delivering securities"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Elanco (ELAN) report for Ellen de Brabander?

Elanco reported that officer Ellen de Brabander received a stock grant and had shares withheld for taxes. She was granted 40,985 common shares and, after tax withholding, directly holds 280,821 Elanco common shares.

How many Elanco (ELAN) shares were granted to Ellen de Brabander?

Ellen de Brabander was granted 40,985 shares of Elanco common stock. The grant carried a recorded price of $0.00 per share, indicating equity compensation rather than a market purchase for cash.

Why were 20,288 Elanco (ELAN) shares disposed of in this Form 4 filing?

20,288 Elanco common shares were disposed of to cover tax obligations. The transaction used code F, indicating a tax-withholding disposition at $23.12 per share, not an open-market sale by the insider.

What is Ellen de Brabander’s Elanco (ELAN) shareholding after these transactions?

After the reported grant and tax withholding, Ellen de Brabander directly holds 280,821 shares of Elanco common stock. This figure reflects her position immediately following the April 1, 2026 transactions.

Was the Elanco (ELAN) Form 4 transaction an open-market buy or sell?

The Form 4 does not show any open-market buy or sell. It records an equity grant of 40,985 shares and a tax-withholding disposition of 20,288 shares, a routine mechanism to cover tax liabilities on share-based compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/07/2026 - 04:30 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

de Brabander Ellen

(Last)

(First)

(Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS

INDIANA

46221

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SEE REMARKS

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/01/2026		A		40,985	A	$0	301,109	D
Common Stock	04/01/2026		F		20,288	D	$23.12	280,821	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

Remarks:

Executive Vice President, Research, Development and Regulatory Affairs

	/s/ Amy C. Seidel, as Attorney-in-Fact for Ellen de Brabander	04/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR